• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.

作者信息

Niki Y, Tamada S, Nakabayashi M, Soejima R

机构信息

Department of Medicine, Kawasaki Medical School, Japan.

出版信息

Drugs. 1995;49 Suppl 2:420-2. doi: 10.2165/00003495-199500492-00121.

DOI:10.2165/00003495-199500492-00121
PMID:8549385
Abstract
摘要

相似文献

1
Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.司帕沙星，一种用于治疗肺炎链球菌呼吸道感染的新一代氟喹诺酮类药物。
Drugs. 1995;49 Suppl 2:420-2. doi: 10.2165/00003495-199500492-00121.
2
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.新型氟喹诺酮类药物HSR-903对呼吸道病原体的体内活性
Antimicrob Agents Chemother. 1998 Apr;42(4):785-8. doi: 10.1128/AAC.42.4.785.
3
Quinolones and pneumococci.喹诺酮类药物与肺炎球菌。
J Antimicrob Chemother. 2000 May;45(5):709-10. doi: 10.1093/jac/45.5.709.
4
Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae.AM-1155对耐青霉素肺炎链球菌的抗菌活性。
J Antimicrob Chemother. 1998 Jan;41(1):103-6. doi: 10.1093/jac/41.1.103.
5
Antimicrobial Activity of Zabofloxacin against Clinically Isolated Streptococcus pneumoniae.扎氟沙星对临床分离肺炎链球菌的抗菌活性
Molecules. 2016 Nov 17;21(11):1562. doi: 10.3390/molecules21111562.
6
Fluoroquinolones as treatment for patients with lower respiratory tract infections caused by Streptococcus pneumoniae.氟喹诺酮类药物用于治疗肺炎链球菌引起的下呼吸道感染患者。
J Antimicrob Chemother. 1998 Sep;42(3):398-9. doi: 10.1093/jac/42.3.398.
7
In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens.司帕沙星与现有抗微生物药物对呼吸道病原体的体外活性比较。
J Antimicrob Chemother. 1996 May;37 Suppl A:1-18. doi: 10.1093/jac/37.suppl_a.1.
8
Activity of grepafloxacin against respiratory isolates of Streptococcus pneumoniae.格帕沙星对肺炎链球菌呼吸道分离株的活性。
Eur J Clin Microbiol Infect Dis. 1997 Aug;16(8):622-3. doi: 10.1007/BF02447932.
9
Gemifloxacin: survival of the fittest.吉米沙星：适者生存。
J Antimicrob Chemother. 2000 Jul;46 Suppl T1:33-7. doi: 10.1093/oxfordjournals.jac.a020892.
10
[Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin].新型喹诺酮类抗菌药物在呼吸道感染中的重要作用：聚焦于司帕沙星
Jpn J Antibiot. 1994 Oct;47(10):1241-58.

引用本文的文献

1
Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.司帕沙星。对其在下呼吸道感染中的抗菌活性、药代动力学特性、临床疗效及耐受性的综述。
Drugs. 1997 Apr;53(4):700-25. doi: 10.2165/00003495-199753040-00010.

本文引用的文献

1
Antimicrobial activity of DV-7751a, a new fluoroquinolone.新型氟喹诺酮类药物DV-7751a的抗菌活性
Antimicrob Agents Chemother. 1993 Oct;37(10):2112-8. doi: 10.1128/AAC.37.10.2112.
2
In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae.司帕沙星对肺炎支原体的体外和体内活性
Antimicrob Agents Chemother. 1994 Apr;38(4):738-41. doi: 10.1128/AAC.38.4.738.
3
In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
新型氟喹诺酮类药物司帕沙星在肺炎小鼠模型中对青霉素敏感、耐药及多重耐药肺炎链球菌菌株的体内疗效。
Antimicrob Agents Chemother. 1992 Dec;36(12):2698-703. doi: 10.1128/AAC.36.12.2698.